About Mine

Mine graduated from Hacettepe University Faculty of Medicine in 2000 and finished her residency training in internal medicine in 2005 in the same university. She has been serving as the consultant of the Acute Care Unit for several years, mainly admitting patients from the emergency department with acute decompensation of chronic diseases; lower respiratory tract infections, organ failure and acute, undiagnosed conditions.

Dr. Mine Durusu Tanriover worked as the Co-Chief of Hacettepe University Oncology Hospital and the Quality Coordinator of Hacettepe University Hospitals, a Joint Commission International accredited, 1200-bed academic medical center between 2016-2020. Her research area mainly consists of adult vaccination, influenza, quality improvement and patient safety. She has been involved in the Global Influenza Hospital Surveillance Network project as an investigator and site coordinator since 2012 and participated as a subinvestigator in the phase 3 clinical trials of COVID-19 vaccines available in Türkiye. Recently, she has been appointed as the primary investigator of the phase 3 clinical trial of TURKOVAC, an inactivated COVID-19 vaccine. She is the author of more than 50 peer-reviewed articles.

Mine is currently leading Hacettepe University Vaccine Institute. She is the founder and the first chair of the Young Internists Working Group and honorary fellow of the European Federation of Internal Medicine (EFIM). She is a member of the Quality and Professional Issues and the Adult Vaccination (ADVICE) Working Groups of EFIM. Dr. Durusu Tanriover is currently the Secretary of the Middle East, Eurasia and Africa Influenza Stakeholders Network and the coordinator of the VACCiMENA-HCP project.

She believes that we are what we eat and inhale, and a healthy life begins with healthy food and being a part of the nature. Her main area of interest outside her academic activities is farming and spending time in her edible balcony garden. She is married with two children.

About Janaka

Janaka is a Clinical Reader (Associate Professor) in Diabetes and Cardiovascular Disease in the School of Cardiovascular Medicine & Sciences at King's College London and Consultant Physician in Diabetes, Endocrinology and General Internal Medicine at Guy’s and St Thomas Hospital London.

He graduated with a distinction in medicine from the University of London and was awarded a PhD for research on the pathophysiology and treatment of cardiovascular disease and renal disease in diabetes. Janaka leads research projects focussed on cardio-renal disease predictors and biomarkers and their potential for real world application to guide risk stratification of people at high risk of rapid progression of kidney disease.

He speaks frequently at national and international meetings, has published more than 100 articles on cardiovascular and renal disease and recently led on the United Kingdom diabetes and kidney association joint guidelines for people with diabetic kidney disease.

He is an active clinician with more than 20 years of experience and specialist expertise managing patients with renal and cardio-vascular complications related to diabetes at Guy’s and St Thomas Hospital and has also established community based cardio-renal metabolic clinics in London focussed on early identification and treatment to reduce cardiovascular and renal complications.

Janaka is passionate about developing and delivering practical clinical medical education and teaches undergraduate and postgraduate students at King’s College London. He is also involved in education of health care professionals and specialist trainees in medicine with a focus on diabetes cardio-renal metabolic complications and their treatment. He is a member of the European Association for the Study of Diabetes (EASD) teaching and education committee and keen to explore new collaborations in his role as associate editor for European Federation of Internal Medicine (EFIM) Academy.